개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한병리학회 Journal of Pathology and Translational Medicine Journal of Pathology and Translational Medicine 제56권 제5호
- 발행연도
- 2022.9
- 수록면
- 281 - 288 (8page)
- DOI
- 10.4132/jptm.2022.07.26
이용수
초록· 키워드
오류제보하기
Background: The aim of the present study was to evaluate the prognostic significance of B-cell lymphocyte kinase (BLK) expression for survival outcomes in diffuse large B-cell lymphoma (DLBCL) patients treated with R-CHOP.Methods: We retrospectively analyzed the medical records of 89 patients from two tertiary referral hospitals. The expression of BLK, SYK, and CDK1 were evaluated in a semiquantitative method using an H-score, and the proportions of BCL2 and C-MYC were evaluated.Results: A total of 89 patients received R-CHOP chemotherapy as a first-line chemotherapy. The expression rates of BLK in tumor cells was 39.2% (n = 34). BLK expression status was not significantly associated with clinical variables; however, BLK expression in tumor cells was significantly associated with the expression of both C-MYC and BCL2 (p = .003). With a median follow-up of 60.4 months, patients with BLK expression had significantly lower 5-year progression-free survival (PFS) and overall survival rates (49.8% and 60.9%, respectively) than patients without BLK expression (77.3% and 86.7%, respectively). In multivariate analysis for PFS, BLK positivity was an independent poor prognostic factor (hazard ratio, 2.208; p = .040).Conclusions: Here, we describe the clinicopathological features and survival outcome according to expression of BLK in DLBCL. Approximately 39% of DLBCL patients showed BLK positivity, which was associated as a predictive marker for poor prognosis in patients who received R-CHOP chemotherapy.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Anti-diabetic effect of HSG4113R repeat oral administration in C57BLKS/J-db/db mice
한국실험동물학회 학술발표대회 논문집
2016 .02
-
Broadband Light Treatment for Multiple Benign Lichenoid Keratoses of Flat Erythematous Type
MEDICAL LASERS
2018 .01
-
Assessment of the clinical heterogeneity of Kawasaki disease using genetic variants of BLK and FCGR2A
Korean Circulation Journal
2019 .01
-
Treatment results of radiotherapy following CHOP or R-CHOP in limited-stage head-and-neck diffuse large B-cell lymphoma: a single institutional experience
Radiation oncology journal : ROJ
2017 .01
-
Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Cancer Research and Treatment
2019 .01
-
Prognostic Implication of Semi-quantitative Immunohistochemical Assessment of CD20 Expression in Diffuse Large B-Cell Lymphoma
Journal of Pathology and Translational Medicine
2016 .01
-
Evaluation of micro-current stimulation for improving insulin resistance and regulating blood glucose in db/db mice
한국실험동물학회 학술발표대회 논문집
2022 .01
-
Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid ymphoma : a multicenter study
Annals of Surgical Treatment and Research
2015 .11
-
Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma
Cancer Research and Treatment
2022 .10
-
Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution Study
Cancer Research and Treatment
2021 .01
-
Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma
Blood Research
2019 .01
-
Clinical impact of CD5 expression in Korean patients with diffuse large B-cell lymphoma
Blood Research
2017 .01
-
Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor Analysis
Cancer Research and Treatment
2015 .01
-
Long Non-coding RNA HOTAIR Expression in Diffuse Large B-Cell Lymphoma: In Relation to Polycomb Repressive Complex Pathway Proteins and H3K27 Trimethylation
Journal of Pathology and Translational Medicine
2016 .01
-
Phase III of Study of R-CHOP-21 vs R-CHOP-14 for Untreated Stage III and IV B-cell Non-Hodgkin's Lymphoma: a Report from Iran
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma
Journal of Pathology and Translational Medicine
2022 .01
-
HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases
Blood Research
2020 .01
-
비부비동 악성 림프종에 대한 임상고찰: 치료방침 및 예후인자
대한이비인후-두경부외과학회지
2024 .09
-
Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer
전남의대학술지
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0